← Open Payments lookup

DAVID SHARP: Open Payments

NPI 1932117470 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,827 in 216 payments from 38 companies in 2025. Trend: 2023 $3,871 · 2024 $3,855 · 2025 $3,827

Food & beverage: $3,745Education: $82
CompanyPaymentsAmount
Amgen Inc.16$365
ABBVIE INC.23$364
Novartis Pharmaceuticals Corporation25$353
Antares Pharma, Inc.29$331
Novo Nordisk Inc21$299
Lilly USA, LLC16$285
PFIZER INC.12$209
Gilead Sciences, Inc.11$208
Boehringer Ingelheim Pharmaceuticals, Inc.13$165
Regeneron Healthcare Solutions, Inc.2$141

Products named: LEQVIO, XYOSTED, OTEZLA, NURTEC ODT, VRAYLAR, Ozempic, EVKEEZA, REPATHA.

Industry payments across NE — which companies pay providers there.